Business
Eris Lifesciences Q4 Result FY26: Profit Triples to ₹281 Crore, But There’s a Major Catch Investors Should Understand
Eris Lifesciences Limited delivered one of the most discussed pharmaceutical earnings reports of Q4 FY26 after announcing its latest quarterly…